5/27/2021 1:30:00 PM
Learn about our preclinical research study
Learn about our preclinical research study using psilocybin and N-Acetylcysteine (“NAC”) for the treatment of mild traumatic brain injury/concussion (“mTBI”) with post-traumatic stress disorder (“PTSD”). The study is in collaboration with a multidisciplinary team of scientists and physicians at the University of Miami's Miller School of Medicine under the lead of Michael E. Hoffer, M.D., professor of otolaryngology and neurological surgery.
-
Meet Lobe Sciences A Life Sciences Company Focused on Psychedelic Medicines
5/27/2021 1:20:00 PM
5/27/2021 1:10:00 PM
5/27/2021 1:02:47 PM
3/2/2021 12:00:00 AM
3/1/2021 3:30:00 AM
3/1/2021 12:00:00 AM
2/28/2021 10:00:00 PM
2/28/2021 3:30:00 AM
2/27/2021 10:00:00 PM
2/27/2021 9:00:00 PM
2/27/2021 7:23:00 PM
2/27/2021 3:30:00 AM
2/26/2021 10:00:00 PM
2/26/2021 9:00:00 PM
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
